SCHEMBL6207789

SCHEMBL6207789

COc1ccc(N(CCc2ccnc(-c3cccc(OC)c3)c2)C2CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
SLC2A1 P11166 1/20 0.48
GPR119 Q8TDV5 4/20 0.46
HTT P42858 2/20 0.44
ABL1 P00519 1/20 0.42
EGFR P00533 1/20 0.42
SRC P12931 1/20 0.42
ABL2 P42684 1/20 0.42
WNK1 Q9H4A3 1/20 0.42
ALDH1A1 P00352 2/20 0.42
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
FGFR3 P22607 1/20 0.41
KDR P35968 1/20 0.41
FLT3 P36888 1/20 0.41
EPHX2 P34913 1/20 0.41
HDAC1 Q13547 1/20 0.41
TGFBR1 P36897 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4122387 0.93 SLC2A1 (0.54) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4116149 0.87 SLC2A1 (0.53) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4117193 0.86 SLC2A1 (0.50) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4108456 0.83 SLC2A1 (0.49) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4117155 0.82 SLC2A1 (0.48) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4126544 0.82 GPR119 (0.50) MEN1KMT2ASLC2A1GPR119HDAC1
SCHEMBL4123371 0.82 SLC2A1 (0.49) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4123730 0.82 GPR119 (0.54) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4123050 0.82 SLC2A1 (0.49) MEN1KMT2ASLC2A1GPR119HTT
SCHEMBL4109784 0.82 SLC2A1 (0.49) MEN1KMT2ASLC2A1GPR119HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494670-A1 MEDICINE FOR TREATING CANCER Kowa Co., Ltd. (JP) 2005-01-12 EP disclosed
WO-2003086397-A1 MEDICINE FOR TREATING CANCER KOWA CO., LTD. (JP) 2003-10-23 WO disclosed